Skip to main content

ALVO · Alvotech

Track ALVO — free
$5.60 -0.02 (-0.36%)
Market Cap
$2.19B
Shares
356.82M
Volume · Oct 1 1.2M Avg daily vol (3M) 989.21K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.62 Open$5.81 Day$5.46–5.82 52W close$3.00–8.98 Avg vol 30d1.3M Short int5.8M · 1.6% float · 8.8d Short vol53% Last earningsMar 11, 2027 DataJun 2022–Oct 2026

Up next

Next earnings call
Nov 12, 2026 Scheduled · in 6 wks
call held Aug 20, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+19.7%
Year over year
Operating margin
13.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.4%
Year over year · more shares
Price change (1Y)
-29.2%
Trailing year
Short interest
1.6%
Latest settlement · 8.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 16.4 · calm Equity put/call 0.57
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +34%
above
Price vs 50-day avg +20%
above
RSI (14) 57
neutral
MACD trend Negative
52-week position 44%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +5%
trailing
6-month return +55%
trailing
YTD return +10%
this year
Relative strength +43%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow Accumulating
+25% holders QoQ · +21 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.63% of float · ▲ +4.0% MoM · 8.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
76 holders — near 3-yr high, broad support
Squeeze score 71
high risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 78%
annualized · 1-yr
Max drawdown −67%
past year
ATR 5.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 20, 2026
Total revenue · 2026 $650M – $700M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+34% Bullish
Price vs 50-day avg
+20% Bullish
RSI (14)
57 Neutral
MACD trend
Negative Bearish
52-week position
44% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow Accumulating
+25% holders QoQ · +21 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.63% of float · ▲ +4.0% MoM · 8.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
76 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $6 · 44% Range high $9
vs 200-day avg +34% vs 50-day avg +20%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ALVO
Alvotech
this stock
$2.19B +9.6% — — 1.6%
TAK
Takeda Pharmaceutical Co Ltd
$60.23B +14.6% — — 0.1%
GALDY
Galderma Group AG/ADR
$46.00B -6.4% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
$45.67B +26.0% +4.3% 64.3 2.7%
HLN
Haleon plc
$40.72B -13.7% — — 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
76
% held
13.4%
Net QoQ
+25.6M sh
Top holder
Rubric Capital Management…
Held Float
View
Held by Funds
Fund positions
13
View
Short & Settlement
Short Interest Rising
Shares short
5.8M
Days to cover
8.8d
Change
+224.5K sh
View
Short Volume
Short vol %
53%
As of
Oct 1, 2026
Short Total
View
Fails to Deliver
FTD shares
1.6K
Value
$8.2K
As of
Sep 8, 2026
View
Off-Exchange
Off-exchange %
43.9%
Week of
Aug 24, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 31, 2026
This year
24
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 12, 2026
Last webcast
Aug 20, 2026
View
Investor Relations
Latest news
Alvotech Announces Financial Resu…
Published
Aug 19, 2026
Upcoming events
5
View

Performance

5D 20D 120D MTD YTD
ALVO -4.4% +5.2% +55.3% -3.1% +9.6%
SPY -0.4% -0.2% +12.4% +0.2% +12.0%
vs SPY -4.0% +5.4% +42.8% -3.3% -2.5%
Key facts CIK 1898416 CUSIP L01800108 13F (30d) 1 filings 1 filers Visit website Investor relations